[Adult T cell leukemia/lymphoma (ATL)].

@article{Tanosaki2003AdultTC,
  title={[Adult T cell leukemia/lymphoma (ATL)].},
  author={Ryuji Tanosaki},
  journal={Nihon rinsho. Japanese journal of clinical medicine},
  year={2003},
  volume={61 9},
  pages={1592-5}
}
  • Ryuji Tanosaki
  • Published 2003 in
    Nihon rinsho. Japanese journal of clinical…
Adult T cell leukemia/lymphoma(ATL) is an aggressive, fatal malignancy associated with human T-lymphotropic virus type I(HTLV-I). The median survival time of acute- and lymphoma-type ATL is 6 and 10 months, respectively. According to recent reports, nearly half of the ATL patients who received allogeneic hematopoietic stem cell transplantation could survive without disease for over 3 years. However, the population of patients who are eligible for conventional transplantation is extremely… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 42 extracted citations

Similar Papers

Loading similar papers…